PEAK PHARMACEUTICALS, INC. Cost of Revenue
PEAK PHARMACEUTICALS, INC. (RMHI) reported Cost of Revenue of $0 for the 3-month period ending 2017-06-30, per its 10-Q filed 2017-09-13.
Discontinued › Expense Statement
us-gaap:CostOfRevenue · last filed 2017-09-13
- PEAK PHARMACEUTICALS, INC. cost of revenue for the quarter ending 2017-06-30 was $0.00.
- PEAK PHARMACEUTICALS, INC. cost of revenue for the quarter ending 2017-03-31 was $0.00.
- PEAK PHARMACEUTICALS, INC. cost of revenue for the quarter ending 2016-12-31 was $0.00.
- PEAK PHARMACEUTICALS, INC. cost of revenue for the quarter ending 2016-06-30 was $0.00.
| Period end | Cost of Revenue 3 month | Cost of Revenue 3 month as first filed | Cost of Revenue 6 month | Cost of Revenue 6 month as first filed | Cost of Revenue 9 month | Cost of Revenue 9 month as first filed |
|---|---|---|---|---|---|---|
| 2017-06-30 | $0.00 10-Q · filed 2017-09-13 | $0.00 derived: sum of 2 quarters · filed 2017-09-13 | $0.00 10-Q · filed 2017-09-13 | |||
| 2017-03-31 | $0.00 10-Q · filed 2017-09-13 | $0.00 10-Q · filed 2017-09-13 | ||||
| 2016-12-31 | $0.00 10-Q · filed 2017-09-13 | |||||
| 2016-06-30 | $0.00 10-Q · filed 2017-09-13 | $0.00 derived: sum of 2 quarters · filed 2017-09-13 | $0.00 10-Q · filed 2017-09-13 | |||
| 2016-03-31 | $0.00 10-Q · filed 2017-09-13 | $0.00 10-Q · filed 2017-09-13 | ||||
| 2015-12-31 | $0.00 10-Q · filed 2017-09-13 | |||||
| 2015-06-30 | $0.00 10-Q · filed 2017-09-13 | $317.24K 10-Q · filed 2015-08-13 | $0.00 derived: sum of 2 quarters · filed 2017-09-13 | $0.00 10-Q · filed 2017-09-13 | $751.31K 10-Q · filed 2015-08-13 | |
| 2015-03-31 | $0.00 10-Q · filed 2017-09-13 | $220.93K 10-Q · filed 2015-05-15 | $0.00 10-Q · filed 2017-09-13 | $382.29K 10-Q · filed 2015-05-15 | ||
| 2014-12-31 | $161.36K 10-Q · filed 2015-02-17 |